Health News-RSS Feeds

Shares of Syneos Health Inc rose 13% after Reuters exclusively reported that the company is making a new effort to sell itself. The effort comes in the wake of a reduced backlog of contracts for providing clinical research to drug developers that led to a plunge in the value of its shares over the past year. Syneos has hired Bank of America Corp and Centerview Partners LLC for financial advice as it embarks on a new round of talks with potential acquirers that may include industry peers and private equity firms. 

The post <strong>Syneos Health eyes sale of company as contract backlog shrinks</strong> appeared first on Reuters News Agency.

Reuters shed light on how U.S. and European airlines will benefit from pent-up demand for travel to China after its recent border reopening, but route approvals, fresh COVID-19 testing rules and not enough large aircrafts remain barriers to rising sales.

The post Reuters reveals Airlines face hurdles to cashing in on China re-opening appeared first on Reuters News Agency.

Reuters exclusively revealed that drugmakers including Pfizer Inc, GlaxoSmithKline PLC, Bristol Myers Squibb, AstraZeneca PLC and Sanofi SA plan to raise prices in the United States on more than 350 unique drugs in early January. The increases are expected to come as the industry prepares for the Biden Administration’s Inflation Reduction Act, which lets the government negotiate prices directly for some drugs, starting in 2026.

The post Reuters reveals drugmakers to raise prices on at least 350 drugs in U.S. in January appeared first on Reuters News Agency.

Reuters exclusively reported that, as COVID-19 infections surge in China, the U.S. Centers for Disease Control and Prevention is considering sampling wastewater taken from international aircrafts to track any emerging new variants.

The post Reuters reveals U.S. considers airline wastewater testing as COVID surges in China appeared first on Reuters News Agency.